摘要 |
<p>This invention relates to novel compounds of the Formula (I)1 (I*), (I**), (Ia), (Ib), (Ic), (Id), (Ie)1 (If), (Ig), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11 ß-HSD1 in mammals. The invention further relates to pharmaceutical compositions of the novel compounds and methods for their use in the reduction or control of the production of Cortisol in a cell or the inhibition of the conversion of cortisone to Cortisol in a cell.</p> |
申请人 |
VITAE PHARMACEUTICALS, INC.;CLAREMON, DAVID, A.;ZHUANG, LINGHANG;YE, YUANJIE;SINGH, SURESH, B.;TICE, COLIN, M. |
发明人 |
CLAREMON, DAVID, A.;ZHUANG, LINGHANG;YE, YUANJIE;SINGH, SURESH, B.;TICE, COLIN, M. |